Work

Supplemental Figure 2 from Human Dendritic Cells Mitigate NK-Cell Dysfunction Mediated by Nonselective JAK1/2 Blockade

Year: 2023

Type: supplementary-materials

Abstract: Inhibition of JAK1/2 with ruxolitinib reduces NK cell numbers and function among treated patients with myeloproliferative neoplasm (MPN).

DOI: 10.1158/2326-6066.22538828

Authors: Shane A. Curran, Justin A. Shyer, Erin T. St. Angelo, Lillian R. Talbot, Sneh Sharma, David J. Chung, Glenn Heller, Katharine C. Hsu, Brian C. Betts, James W. Young

Language: English

Topic: Immune Cell Function and Interaction

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362567532

Cites:

Cited by:

Related to: 10